Literature DB >> 34949863

Applications of and considerations for using CRISPR-Cas9-mediated gene conversion systems in rodents.

Hannah A Grunwald1, Alexander J Weitzel1, Kimberly L Cooper2.   

Abstract

Genetic elements that are inherited at super-Mendelian frequencies could be used in a 'gene drive' to spread an allele to high prevalence in a population with the goal of eliminating invasive species or disease vectors. We recently demonstrated that the gene conversion mechanism underlying a CRISPR-Cas9-mediated gene drive is feasible in mice. Although substantial technical hurdles remain, overcoming these could lead to strategies that might decrease the spread of rodent-borne Lyme disease or eliminate invasive populations of mice and rats that devastate island ecology. Perhaps more immediately achievable at moderate gene conversion efficiency, applications in a laboratory setting could produce complex genotypes that reduce the time and cost in both dollars and animal lives compared with Mendelian inheritance strategies. Here, we discuss what we have learned from early efforts to achieve CRISPR-Cas9-mediated gene conversion, potential for broader applications in the laboratory, current limitations, and plans for optimizing this potentially powerful technology.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34949863     DOI: 10.1038/s41596-021-00646-7

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  73 in total

1.  Genome editing. The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations.

Authors:  Valentino M Gantz; Ethan Bier
Journal:  Science       Date:  2015-03-19       Impact factor: 47.728

Review 2.  Rodent-borne diseases and their risks for public health.

Authors:  Bastiaan G Meerburg; Grant R Singleton; Aize Kijlstra
Journal:  Crit Rev Microbiol       Date:  2009       Impact factor: 7.624

3.  Self-destructing mosquitoes and sterilized rodents: the promise of gene drives.

Authors:  Megan Scudellari
Journal:  Nature       Date:  2019-07       Impact factor: 49.962

4.  Controversial CRISPR 'gene drives' tested in mammals for the first time.

Authors:  Ewen Callaway
Journal:  Nature       Date:  2018-07       Impact factor: 49.962

5.  CRISPR-Cas9 knockin mice for genome editing and cancer modeling.

Authors:  Randall J Platt; Sidi Chen; Yang Zhou; Michael J Yim; Lukasz Swiech; Hannah R Kempton; James E Dahlman; Oren Parnas; Thomas M Eisenhaure; Marko Jovanovic; Daniel B Graham; Siddharth Jhunjhunwala; Matthias Heidenreich; Ramnik J Xavier; Robert Langer; Daniel G Anderson; Nir Hacohen; Aviv Regev; Guoping Feng; Phillip A Sharp; Feng Zhang
Journal:  Cell       Date:  2014-09-25       Impact factor: 41.582

6.  A brief history of animal modeling.

Authors:  Aaron C Ericsson; Marcus J Crim; Craig L Franklin
Journal:  Mo Med       Date:  2013 May-Jun

7.  Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi.

Authors:  Valentino M Gantz; Nijole Jasinskiene; Olga Tatarenkova; Aniko Fazekas; Vanessa M Macias; Ethan Bier; Anthony A James
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

Review 8.  Concerning RNA-guided gene drives for the alteration of wild populations.

Authors:  Kevin M Esvelt; Andrea L Smidler; Flaminia Catteruccia; George M Church
Journal:  Elife       Date:  2014-07-17       Impact factor: 8.140

9.  Super-Mendelian inheritance mediated by CRISPR-Cas9 in the female mouse germline.

Authors:  Hannah A Grunwald; Valentino M Gantz; Gunnar Poplawski; Xiang-Ru S Xu; Ethan Bier; Kimberly L Cooper
Journal:  Nature       Date:  2019-01-23       Impact factor: 49.962

10.  Tissue-specific expression of Cas9 has no impact on whole-body metabolism in four transgenic mouse lines.

Authors:  Simon T Bond; Aowen Zhuang; Christine Yang; Eleanor A M Gould; Tim Sikora; Yingying Liu; Ying Fu; Kevin I Watt; Yanie Tan; Helen Kiriazis; Graeme I Lancaster; Paul Gregorevic; Darren C Henstridge; Julie R McMullen; Peter J Meikle; Anna C Calkin; Brian G Drew
Journal:  Mol Metab       Date:  2021-07-08       Impact factor: 7.422

View more
  1 in total

Review 1.  Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing.

Authors:  Tianxu Fang; Xiaona Cao; Mysha Ibnat; Guojun Chen
Journal:  J Nanobiotechnology       Date:  2022-08-02       Impact factor: 9.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.